ICRU report 38: Has the radiation oncology community accepted it? [1]

Clinical Oncology

Volumn 14, Issue 5, 2002, Pages 430-431

  Rath, G K ^a   Sharma, D N ^a   Julka, P K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; ITALY; LETTER; MEDLINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; UTERINE CERVIX CANCER;

EID: 0036786737     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2002.0105     Document Type: Letter

References (12)

1. International Commission on Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary therapy in gynecology, ICRU Report, 38. Bethesda MD: ICRU, 1985.
2. Grigsby PW, Winter K, Wasserman TH, et al. Irradiation with or without misonidazole for patients with stages IIIb and IVa carcinoma of the cervix: final results of RTOG, 80-05. Int J Radiat Oncol Biol Phys 1999;44(3):513-517.
3. Perez CA, Grigsby PW, Lockett MA, Chao KSC, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999:44(4):855-866.
4. Chen SW, Liang JA, Yang SN, Liu RT, Lin FJ. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2000;47(4):955-961.
5. Barrilot I, Horiot JC, Maingon P, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies. Int J Radiat Oncol Biol Phys2000;48(l):189-200.
6. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48(1):201-211.
7. Katz A, Eifel P. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2001;48(5): 1417-1425.
8. Potter R, Limbergen EV, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001;58:11-18.
9. International Commission on Radiation Units and Measurements (ICRU). Dose specification for reporting external bean therapy with photons and electrons, ICRU Report, 29. Bethesda, MD: ICRU, 1978.
10. International Commission of Radiation Units and Measurements (ICRU). Prescribing, recording and reporting photon beam therapy, ICRU Report, 50. Bethesda, MD: ICRU, 1993.
11. International Commission of Radiation Units and Measurements (ICRU). Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50), ICRU Report, 62, Bethesda, MD: ICRU, 1999.
12. Bolla M, Bartelink H, Garavaglia G et al. EORTC guidelines for writing protocols for clinical trials. Radiother Oncol 1995; 36:1-8.